Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Histopathological Diagnosis of Primary Central Nervous System Lymphoma After Preoperative Corticosteroid Therapy

Version 1 : Received: 20 February 2024 / Approved: 21 February 2024 / Online: 21 February 2024 (04:02:28 CET)

A peer-reviewed article of this Preprint also exists.

Feldheim, J.; Darkwah Oppong, M.; Feldheim, J.A.; Jabbarli, R.; Dammann, P.; Uerschels, A.-K.; Gembruch, O.; Ahmadipour, Y.; Deuschl, C.; Junker, A.; Sure, U.; Wrede, K.H. Histopathological Diagnosis of Primary Central Nervous System Lymphoma after Therapy with Corticosteroids or Anticoagulants. Cancers 2024, 16, 1157. Feldheim, J.; Darkwah Oppong, M.; Feldheim, J.A.; Jabbarli, R.; Dammann, P.; Uerschels, A.-K.; Gembruch, O.; Ahmadipour, Y.; Deuschl, C.; Junker, A.; Sure, U.; Wrede, K.H. Histopathological Diagnosis of Primary Central Nervous System Lymphoma after Therapy with Corticosteroids or Anticoagulants. Cancers 2024, 16, 1157.

Abstract

In patients with primary central nervous system lymphoma (PCNSL), the choice of surgical strategy for histopathologic assessment is still controversial, particularly in terms of preoperative corticosteroid (CS) therapy. To provide further evidence for clinical decision-making, we retrospectively analyzed data from 148 consecutive patients who underwent surgery at our institution. Although patients treated with corticosteroids preoperatively were significantly more likely to require a second or third biopsy (p=0.049), it was only necessary in less than 10% of the cases with preoperative corticosteroid treatment. The choice of surgical procedure did not affect diagnostic accuracy (p>0.05). Preoperative CSF sampling did not provide additional information but was associated with delayed surgery (p=0.02). Surprisingly, diagnostic accuracy was significantly lower when patients were treated with anticoagulation or dual antiplatelet therapy (p=0.015). In conclusion, preoperative CS therapy can challenge the histological diagnosis of PCNSL. At the same time, our data suggest that preoperative CS treatment only presents a relative contraindication for an early surgical intervention. The standard surgical approach is stereotactic biopsy, but other approaches can be individually considered. If a definitive diagnosis cannot be made after the first surgical intervention, the timing of a repeat biopsy after discontinuation of CS remains a case-by-case decision.

Keywords

primary central nervous system lymphoma; stereotactic biopsy; corticosteroid; histopathology; brain tumor

Subject

Medicine and Pharmacology, Clinical Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.